Convergence insufficiency is a common problem of binocular vision, affecting 2.25-8.3% of the population, 1 and its symptoms were fi rst described by von Graefe in 1855. 2 Clinically, it presents with a reduced near point of convergence, reduced convergence amplitudes, and a near exophoria or intermittent tropia that exceeds that of the distance. Symptoms include any or all of diplopia, asthenopia, headaches, and/or blurred vision while performing near tasks. 3 The inevitable goal of treatment is to improve symptoms and fusional convergence by improving clinical signs of convergence insuffi ciency. Nonsurgical treatment for convergence insuffi ciency (CI) typically includes (but is not limited to) home-based pencil push-ups, stereograms or vectographs, home-based com-ABSTRACT Background and Purpose: Orthoptic exercises are routinely prescribed to treat symptoms of convergence insuffi ciency (CI). The type and duration of treatment tends to vary among providers as until recently, few strong randomized control studies have addressed the effi cacy of convergence insuffi ciency management. The aim of this paper is to address these studies and discuss their limitations.
INTRODUCTION
Convergence insufficiency is a common problem of binocular vision, affecting 2.25-8.3% of the population, 1 and its symptoms were fi rst described by von Graefe in 1855. 2 Clinically, it presents with a reduced near point of convergence, reduced convergence amplitudes, and a near exophoria or intermittent tropia that exceeds that of the distance. Symptoms include any or all of diplopia, asthenopia, headaches, and/or blurred vision while performing near tasks. 3 The inevitable goal of treatment is to improve symptoms and fusional convergence by improving clinical signs of convergence insuffi ciency. Nonsurgical treatment for convergence insuffi ciency (CI) typically includes (but is not limited to) home-based pencil push-ups, stereograms or vectographs, home-based com-
ABSTRACT
Background and Purpose: Orthoptic exercises are routinely prescribed to treat symptoms of convergence insuffi ciency (CI). The type and duration of treatment tends to vary among providers as until recently, few strong randomized control studies have addressed the effi cacy of convergence insuffi ciency management. The aim of this paper is to address these studies and discuss their limitations.
Methods: A review of the literature pertaining to convergence insuffi ciency was conducted. Articles relevant to the treatment of this disorder were analyzed, and those with adequate studies pertaining to CI treatment methods were included.
Results: There are limited randomized control trials evaluating the effectiveness of vision therapy, and those that do exist have limitations: small patient populations, differing outcome measures, treatment length and intensity, and placebo effects, which are all confounding factors when assessing the validity of the current studies.
Conclusion: Despite the prevalence of convergence insuffi ciency, the known effi cacy of vision therapy remains somewhat questionable. There is evidence to suggest that some form of therapy is effective in reducing symptoms and clinical fi ndings of convergence insuffi ciency, but there is a lack of equal comparison in order to conclude which forms of treatment are best.
LITERATURE RESULTS
The Cochrane Review in 2011 revealed 529 titles/ abstracts addressing convergence insuffi ciency. Of these studies, the review only found six randomized control trials (RCT), looking at 475 patients with symptomatic convergence insufficiency. The remaining titles were largely retrospective and/or case studies, with very small patient populations. 12 Four of the 6 RCTs came from the Convergence Insufficiency Treatment Trial (CITT) group, and only one study had a large patient population of greater than 100. 13 The studies reviewed addressed both the effectiveness of active nonsurgical treatment for CI, 1, [13] [14] [15] as well as passive treatment using base-in prism reading glasses. 4, 5 The results from these RCTs suggest that offi ce-based vision therapy/ orthoptics with home reinforcement is more effective than home-based therapy alone at improving both the symptoms and clinical signs in children with symptomatic CI. 1, 13 Similar results were also found in young adults 15 and adults.
14 Base-in prism reading glasses were found to be no more effective than placebo reading glasses for improving symptoms and clinical signs in children; 4 however, they were more effective in reducing symptoms in presbyopic adults. 5 
PROBLEMS WITH CURRENT STUDIES
As mentioned, of the 529 titles addressing convergence insufficiency, only six were RCTs, and only one of which had a large patient population.
The CITT study in 2008 had 221 participants, while the next two largest studies were the CITT study evaluating the effectiveness of base-in prism glasses, 4 and the study conducted by Birnbaum in 1999 evaluating the effi cacy of vision therapy in adult males, 14 with seventy-two and sixty patients respectively. The remainputer orthoptic therapy, and offi ce-based vision therapy. 1, 3 Base-in prisms can also be used to alleviate symptoms of CI. 4, 5 It is thought that use of pencil-push ups is the most commonly prescribed treatment for symptomatic CI, 6 although many providers recommend supplementing pencil push-ups with other forms of therapy or exercises for maximal results. 7 Questions arise when addressing the effi cacy of these common treatments, and whether some are more effective than others. Despite the notion that pencil push-ups are the most commonly prescribed treatment, the type and duration of treatment still varies among providers. Until recently, there have been few randomized control studies addressing efficacy of the common treatment modalities. These studies are limited, however, as they do not provide equal comparison.
VISION THERAPY VS. ORTHOPTIC THERAPY
Vision therapy has become somewhat of an "umbrella-term" for many treatment types, and often has a negative connotation to pediatric ophthalmologists and orthoptists. 8 It can include treatment for a wide range of disorders including those of the underachieving child, neurological disorders, learning and reading disabilities, spatial issues, as well as others, with a lack of scientific evidence supporting treatment for these problems.
9-11 However, there is convincing scientifi c data to support vision therapy for convergence insufficiency, but it is often referred to more commonly as orthoptic or vergence therapy. Volume 63, 2013 was administered (the "dose") was not equal: home-based therapy groups did not provide an ideal comparison, nor did they receive as much therapy time as the offi ce-based groups. 7, 18 Equal time distributed over the treatment groups would give a more accurate comparison of treatment modalities. In addition, the total treatment length varied considerably from study to study, from 6 weeks in Teitelbaum's study, to 12 weeks in the CITT studies, to 26 weeks in Birnbaum's study. Despite this discrepancy, each study showed improvement following therapy.
1, 4, 5, 13-15 The differing treatment lengths do not reveal a maximum treatment effect that could possibly be achieved; therefore, no conclusion can be drawn as to how long treatment is necessary for a successful outcome.
One cannot overlook the placebo effect that may exist within treatment and these studies. 12 Placebo response rates have been reported in the literature between 15-58% with an average placebo effectiveness of 35%. 19 Randomized patients in these studies did not receive equal interaction with their providers, as those who were randomized to the offi ce-based groups received more time. Another important note is that no study included a notreatment control group for comparison, which may play a role in compliance. Compliance varied among treatment groups, which may compound actual treatment time. 8 The home-based groups in the CITT studies had a higher rate of noncompliance than those in the offi ce-based therapy groups, 1, 4, 13, 15 which may be in part due to less patient-provider interaction than with the offi ce-based therapy groups. 8 Lastly, these studies do not address the underlying epidemiology of convergence insufficiency and its natural history. 17 There was not a no-treatment group and therefore no comparison between treatment groups and those receiving no treatment was made. This then does not ading studies had patient populations of less than fi fty, and 2 of the 6 studies had a high risk for bias. 12 In addition, there was not a consistent primary outcome measure when evaluating success of treatment. The CITT studies all used the convergence insuffi ciency symptom survey (CISS) as the primary outcome measure, with improvement in clinical fi ndings as the secondary outcome. 1, 4, 13, 15 The outcome in the study conducted by Birnbaum was not explicitly specifi ed, 12, 14 and symptom improvement by patient report was the only outcome measure in Teitelbaum's study. 5 This can be diffi cult to conclude what "successful" treatment may be when the defi nition of "success" is not consistent.
Another problem when looking at the CITT studies is the convergence insufficiency symptom survey itself. The CISS is a survey consisting of fi fteen questions with answers regarding symptom frequency directed to a fi ve-point scale ranging from "always" to "never". 16 Many of these questions are similar and/or overlap, which may skew the overall score to favor symptomatic convergence insufficiency. What one may consider a "normal" patient may in fact achieve an equivocal score using the CISS as one with "true" convergence insuffi ciency, as the responses and scores are completely subjective. This survey has shown to be reliable and valid among children, 16 but has not been compared or tested in a group of poor readers. One would suspect that poor readers would also have reduced near skills and by testing the CISS within this group, more validity to the survey may be achieved. dress why some patients are symptomatic and others are not, and why some patients respond to treatment while others do not. These studies also do not address the incidence of symptoms within those with clinical signs of CI. 17 
IS TREATMENT FOR CONVERGENCE INSUFFICIENCY EFFECTIVE?
There is a lot of evidence supporting the role for vision therapy or orthoptic therapy for the treatment of symptomatic CI. There is still limited agreement as to not only which treatments are most effective but also the amount and length that is required for resolution of this condition. The current studies indicate that offi cebased therapy is more effective at reducing symptoms and clinical fi nding of CI than home-based therapies alone; 1, 13, 15 however, these studies are not equally comparative. 7, 8 The economics of home-based therapies versus offi ce-based treatment must also be considered, especially with a decrease in health care dollars available. Further studies comparing home-based therapies would help to further understand the effi cacy of more commonly prescribed therapies for CI, and would help to determine treatment effectiveness versus cost. 8 Evaluation of the natural history of convergence insuffi ciency may also help us to further understand this disorder. 17 Until larger, placebo-controlled, multi center randomized control studies are obtained for further evaluation of the effi cacy of more commonly prescribed treatment for symptomatic CI, this question of effectiveness remains unanswered.
